Epigenetic studies in Alzheimer's disease: Current findings, caveats, and considerations for future studies

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 8, 2013, Pages 789-799

  Lunnon, Katie ^a   Mill, Jonathan ^a,b  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Brain; Dementia; DNA methylation; Genetics; Neurodegeneration

Indexed keywords

DNA METHYLTRANSFERASE; GLUTATHIONE TRANSFERASE P1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 6; HISTONE H4; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CHEMICAL MODIFICATION; CIRCADIAN RHYTHM; CPG ISLAND; DIFFUSE LEWY BODY DISEASE; DNA METHYLATION; DNA MODIFICATION; DNA SEQUENCE; ENTORHINAL CORTEX; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; LEARNING; MEMORY; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; TEMPORAL CORTEX; TISSUE SPECIFICITY;

BRAIN; DEMENTIA; DNA METHYLATION; GENETICS; NEURODEGENERATION;

ALZHEIMER DISEASE; EPIGENESIS, GENETIC; EPIGENOMICS; GENETIC VARIATION; GENOME, HUMAN; HUMANS;

EID: 84887100129     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32201     Document Type: Article

References (130)

1. Aran D, Toperoff G, Rosenberg M, Hellman A. 2011. Replication timing-related and gene body-specific methylation of active human genes. Hum Mol Genet 20(4):670-680.
2. Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ. 2000. Microglia, amyloid and dementia in alzheimer disease. A correlative study. Neurobiol Aging 21(1):39-47.
3. Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, Albin RL, Hu H, Rozek LS. 2012. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis 29(3):571-588.
4. Balazs R, Vernon J, Hardy J. 2011. Epigenetic mechanisms in Alzheimer's disease: Progress but much to do. Neurobiol Aging 32(7):1181-1187.
5. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, Park IH, Xie B, Daley GQ, Church GM. 2009. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 27(4):361-368.
6. Barksdale KA, Perez-Costas E, Gandy JC, Melendez-Ferro M, Roberts RC, Bijur GN. 2010. Mitochondrial viability in mouse and human postmortem brain. FASEB J 24(9):3590-3599.
7. Barton AJ, Pearson RC, Najlerahim A, Harrison PJ. 1993. Pre- and postmortem influences on brain RNA. J Neurochem 61(1):1-11.
8. Bassett SS, Avramopoulos D, Perry RT, Wiener H, Watson B Jr, Go RC, Fallin MD. 2006. Further evidence of a maternal parent-of-origin effect on chromosome 10 in late-onset Alzheimer's disease. Am J Med Genet Part B 141B(5):537-540.
9. Bell CG, Finer S, Lindgren CM, Wilson GA, Rakyan VK, Teschendorff AE, Akan P, Stupka E, Down TA, Prokopenko I, Morison IM, Mill J, Pidsley R, Deloukas P, Frayling TM, Hattersley AT, McCarthy MI, Beck S, Hitman GA. 2010. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS ONE 5(11):e14040.
10. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414):57-74.
11. Blalock EM, Buechel HM, Popovic J, Geddes JW, Landfield PW. 2011. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease. J Chem Neuroanat 42(2):118-126.
12. Blennow K, de Leon MJ, Zetterberg H. 2006. Alzheimer's disease. Lancet 368(9533):387-403.
13. Boks MP, de Jong NM, Kas MJ, Vinkers CH, Fernandes C, Kahn RS, Mill J, Ophoff RA. 2012. Current status and future prospects for epigenetic psychopharmacology. Epigenetics 7(1):20-28.
14. Booij BB, Lindahl T, Wetterberg P, Skaane NV, Saebo S, Feten G, Rye PD, Kristiansen LI, Hagen N, Jensen M, Bardsen K, Winblad B, Sharma P, Lonneborg A. 2011. A gene expression pattern in blood for the early detection of Alzheimer's disease. J Alzheimers Dis 23(1):109-119.
15. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. 2007. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3(3):186-191.
16. Chouliaras L, Rutten BP, Kenis G, Peerbooms O, Visser PJ, Verhey F, van Os J, Steinbusch HW, van den Hove DL. 2010. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol 90(4):498-510.
17. Chouliaras L, Mastroeni D, Delvaux E, Grover A, Kenis G, Hof PR, Steinbusch HW, Coleman PD, Rutten BP, van den Hove DL. 2013. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol Aging 34(9):2091-2099.
18. Cook RH, Schneck SA, Clark DB. 1981. Twins with Alzheimer's disease. Arch Neurol 38(5):300-301.
19. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, Coarfa C, Harris RA, Milosavljevic A, Troakes C, Al-Sarraj S, Dobson R, Schalkwyk LC, Mill J. 2012. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 13(6):R43.
20. Dolinoy DC, Jirtle RL. 2008. Environmental epigenomics in human health and disease. Environ Mol Mutagen 49(1):4-8.
21. Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, Morris JC. 1996. Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance. Neurology 47(1):254-256.
22. Fehlbaum-Beurdeley P, Jarrige-Le Prado AC, Pallares D, Carriere J, Guihal C, Soucaille C, Rouet F, Drouin D, Sol O, Jordan H, Wu D, Lei L, Einstein R, Schweighoffer F, Bracco L. 2010. Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression. Alzheimers Dement 6(1):25-38.
23. Fehlbaum-Beurdeley P, Sol O, Desire L, Touchon J, Dantoine T, Vercelletto M, Gabelle A, Jarrige AC, Haddad R, Lemarie JC, Zhou W, Hampel H, Einstein R, Vellas B. 2012. Validation of AclarusDx, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease. J Alzheimers Dis 32(1):169-181.
24. Flores K, Wolschin F, Corneveaux JJ, Allen AN, Huentelman MJ, Amdam GV. 2012. Genome-wide association between DNA methylation and alternative splicing in an invertebrate. BMC Genomics 13:480.
25. Furuya TK, Silva PN, Payao SL, Bertolucci PH, Rasmussen LT, De Labio RW, Braga IL, Chen ES, Turecki G, Mechawar N, Mill J, Smith MA. 2012. Analysis of SNAP25 mRNA expression and promoter DNA methylation in brain areas of Alzheimer's disease patients. Neuroscience 220:41-46.
26. Gamazon ER, Badner JA, Cheng L, Zhang C, Zhang D, Cox NJ, Gershon ES, Kelsoe JR, Greenwood TA, Nievergelt CM, Chen C, McKinney R, Shilling PD, Schork NJ, Smith EN, Bloss CS, Nurnberger JI, Edenberg HJ, Foroud T, Koller DL, Scheftner WA, Coryell W, Rice J, Lawson WB, Nwulia EA, Hipolito M, Byerley W, McMahon FJ, Schulze TG, Berrettini WH, Potash JB, Zandi PP, Mahon PB, McInnis MG, Zollner S, Zhang P, Craig DW, Szelinger S, Barrett TB, Liu C. 2013. Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry. 18(3):340-346.
27. Gandhi S, Wood NW. 2010. Genome-wide association studies: The key to unlocking neurodegeneration? Nat Neurosci 13(7):789-794.
28. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL. 2006. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63(2):168-174.
29. Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, Chao MV, Mufson EJ, Nixon RA, Che S. 2010. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry 68(10):885-893.
30. Globisch D, Munzel M, Muller M, Michalakis S, Wagner M, Koch S, Bruckl T, Biel M, Carell T. 2010. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE 5(12):e15367.
31. Graff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, Nieland TJ, Fass DM, Kao PF, Kahn M, Su SC, Samiei A, Joseph N, Haggarty SJ, Delalle I, Tsai LH. 2012. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483(7388):222-226.
32. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J. 2013. TREM2 variants in Alzheimer's disease. N Engl J Med 368(2):117-127.
33. Guintivano J, Aryee M, Kaminsky Z. 2013. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics 8(3):290-302.
34. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, Balazer JA, Eaves HL, Xie B, Ford E, Zhang K, Ming GL, Gao Y, Song H. 2011. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 14(10):1345-1351.
35. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, Briem E, Zhang K, Irizarry RA, Feinberg AP. 2011. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43(8):768-775.
36. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297(5580):353-356.
37. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J. 2009. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41(10):1088-1093.
38. Heijmans BT, Mill J. 2012. Commentary: The seven plagues of epigenetic epidemiology. Int J Epidemiol 41(1):74-78.
39. Hellman A, Chess A. 2007. Gene body-specific methylation on the active X chromosome. Science 315(5815):1141-1143.
40. Henikoff S, Matzke MA. 1997. Exploring and explaining epigenetic effects. Trends Genet 13(8):293-295.
41. Hernandez DG, Nalls MA, Gibbs JR, Arepalli S, van der Brug M, Chong S, Moore M, Longo DL, Cookson MR, Traynor BJ, Singleton AB. 2011. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet 20(6):1164-1172.
42. Heyn H, Esteller M. 2012. DNA methylation profiling in the clinic: Applications and challenges. Nat Rev Genet 13(10):679-692.
43. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4(1):97-100.
44. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ER, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Ruther E, Schurmann B, Heun R, Kolsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Gallacher J, Hull M, Rujescu D, Giegling I, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, van Duijn CM, Breteler MM, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, Berr C, Campion D, Epelbaum J, Dartigues JF, Tzourio C, Alperovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snaedal J, Bjornsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossu P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O'Donovan M, Amouyel P, Williams J. 2011. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43(5):429-435.
45. Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, van den Berg LH, Ophoff RA. 2012. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol 13(10):R97.
46. Inoue A, Shen L, Dai Q, He C, Zhang Y. 2011. Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development. Cell Res 21(12):1670-1676.
47. Irier HA, Jin P. 2012. Dynamics of DNA methylation in aging and Alzheimer's disease. DNA Cell Biol 31(Suppl 1):S42-S8.
48. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. 1997a. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56(9):965-973.
49. Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, Hyman BT. 1997b. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17(18):7053-7059.
50. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. 2011. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047):1300-1303.
51. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293(5532):1074-1080.
52. Jin SG, Wu X, Li AX, Pfeifer GP. 2011. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 39(12):5015-5024.
53. Johnson MB, Kawasawa YI, Mason CE, Krsnik Z, Coppola G, Bogdanovic D, Geschwind DH, Mane SM, State MW, Sestan N. 2009. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 62(4):494-509.
54. Jonsson T, Stefansson H, Ph DS, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K. 2013. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368(2):107-116.
55. Jost BC, Grossberg GT. 1995. The natural history of Alzheimer's disease: A brain bank study. J Am Geriatr Soc 43(11):1248-1255.
56. Khaitovich P, Muetzel B, She X, Lachmann M, Hellmann I, Dietzsch J, Steigele S, Do HH, Weiss G, Enard W, Heissig F, Arendt T, Nieselt-Struwe K, Eichler EE, Paabo S. 2004. Regional patterns of gene expression in human and chimpanzee brains. Genome Res 14(8):1462-1473.
57. Khare T, Pai S, Koncevicius K, Pal M, Kriukiene E, Liutkeviciute Z, Irimia M, Jia P, Ptak C, Xia M, Tice R, Tochigi M, Morera S, Nazarians A, Belsham D, Wong AH, Blencowe BJ, Wang SC, Kapranov P, Kustra R, Labrie V, Klimasauskas S, Petronis A. 2012. 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat Struct Mol Biol 19(10):1037-1043.
58. Klose RJ, Bird AP. 2006. Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci 31(2):89-97.
59. Knapp M, Prince M. 2007. The full report. Dementia, UK: Alzheimer's Society.
60. Kriaucionis S, Heintz N. 2009. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929):929-930.
61. Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken RH, Webster MJ, Dinkins T, Callinan PA, Fan JB, Potash JB, Feinberg AP. 2007. DNA methylation signatures within the human brain. Am J Hum Genet 81(6):1304-1315.
62. Lapane KL, Gambassi G, Landi F, Sgadari A, Mor V, Bernabei R. 2001. Gender differences in predictors of mortality in nursing home residents with AD. Neurology 56(5):650-654.
63. Li W, Liu M. 2011. Distribution of 5-hydroxymethylcytosine in different human tissues. J Nucleic Acids 2011:870726.
64. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271):315-322.
65. Lubin FD, Roth TL, Sweatt JD. 2008. Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 28(42):10576-10586.
66. Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Coppola G, Geschwind D, Simmons A, Lovestone S, Dobson R, Hodges A. 2012. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. J Alzheimers Dis 30(3):685-710.
67. Lunnon K, Sattlecker M, Furney S, Coppola G, Simmons A, Proitsi P, Lupton MK, Lourdusamy A, Johnston C, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Geschwind D, Lovestone S, Dobson R, Hodges A. 2013. A blood gene expression marker of early Alzheimer's disease. J Alzheimers Dis 33(3):737-753.
68. Lyko F, Foret S, Kucharski R, Wolf S, Falckenhayn C, Maleszka R. 2010. The honey bee epigenomes: Differential methylation of brain DNA in queens and workers. PLoS Biol 8(11):e1000506.
69. Ma DK, Marchetto MC, Guo JU, Ming GL, Gage FH, Song H. 2010. Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat Neurosci 13(11):1338-1344.
70. Martin DI, Cropley JE, Suter CM. 2011. Epigenetics in disease: Leader or follower? Epigenetics 6(7):843-848.
71. Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD. 2009. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS ONE 4(8):e6617.
72. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. 2010. Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation. Neurobiol Aging 31(12):2025-2037.
73. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. 2011. Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging 32(7):1161-1180.
74. Matevossian A, Akbarian S. 2008. Neuronal nuclei isolation from human postmortem brain tissue. J Vis Exp (20). pii: 914.
75. Meaburn EL, Schalkwyk LC, Mill J. 2010. Allele-specific methylation in the human genome: Implications for genetic studies of complex disease. Epigenetics 5(7):578-582.
76. Meda L, Baron P, Scarlato G. 2001. Glial activation in Alzheimer's disease: The role of Abeta and its associated proteins. Neurobiol Aging 22(6):885-893.
77. Mill J. 2011. Toward an integrated genetic and epigenetic approach to Alzheimer's disease. Neurobiol Aging 32(7):1188-1191.
78. Mill J, Heijmans BT. 2013. From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet 14(8):585-594.
79. Mill J, Petronis A. 2007. Molecular studies of major depressive disorder: The epigenetic perspective. Mol Psychiatry 12(9):799-814.
80. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang SC, Petronis A. 2008. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 82(3):696-711.
81. Munzel M, Globisch D, Bruckl T, Wagner M, Welzmiller V, Michalakis S, Muller M, Biel M, Carell T. 2010. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angew Chem Int Ed Engl 49(31):5375-5377.
82. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD. 2011. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43(5):436-441.
83. Nakahata Y, Grimaldi B, Sahar S, Hirayama J, Sassone-Corsi P. 2007. Signaling to the circadian clock: Plasticity by chromatin remodeling. Curr Opin Cell Biol 19(2):230-237.
84. Nebbioso A, Carafa V, Benedetti R, Altucci L. 2012. Trials with 'epigenetic' drugs: An update. Mol Oncol 6(6):657-682.
85. Nee LE, Lippa CF. 1999. Alzheimer's disease in 22 twin pairs-13-year follow-up: Hormonal, infectious and traumatic factors. Dement Geriatr Cogn Disord 10(2):148-151.
86. Neumann H, Daly MJ. 2013. Variant TREM2 as risk factor for Alzheimer's disease. N Engl J Med 368(2):182-184.
87. Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G II, Jiang L, Kang J, Nedergaard M, Goldman SA. 2003. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 9(4):439-447.
88. Odagiri S, Tanji K, Mori F, Miki Y, Kakita A, Takahashi H, Wakabayashi K. 2013. Brain expression level and activity of HDAC6 protein in neurodegenerative dementia. Biochem Biophys Res Commun 430(1):394-399.
89. Ogawa O, Zhu X, Lee HG, Raina A, Obrenovich ME, Bowser R, Ghanbari HA, Castellani RJ, Perry G, Smith MA. 2003. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: A mitotic catastrophe? Acta Neuropathol 105(5):524-528.
90. Olah M, Raj D, Brouwer N, De Haas AH, Eggen BJ, Den Dunnen WF, Biber KP, Boddeke HW. 2012. An optimized protocol for the acute isolation of human microglia from autopsy brain samples. Glia 60(1):96-111.
91. Penn NW, Suwalski R, O'Riley C, Bojanowski K, Yura R. 1972. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem J 126(4):781-790.
92. Pidsley R, Mill J. 2011. Epigenetic studies of psychosis: Current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry 69(2):146-156.
93. Pieper HC, Evert BO, Kaut O, Riederer PF, Waha A, Wullner U. 2008. Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability. Neurobiol Dis 32(3):521-527.
94. Pietersen CY, Lim MP, Woo TU. 2009. Obtaining high quality RNA from single cell populations in human postmortem brain tissue. J Vis Exp (30):pii: 1444.
95. Plomin R, Owen MJ, McGuffin P. 1994. The genetic basis of complex human behaviors. Science 264(5166):1733-1739.
96. Rao JS, Keleshian VL, Klein S, Rapoport SI. 2012. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl Psychiatry 2:e132.
97. Rauch TA, Wu X, Zhong X, Riggs AD, Pfeifer GP. 2009. A human B cell methylome at 100-base pair resolution. Proc Natl Acad Sci USA 106(3):671-678.
98. Relton CL, Davey Smith G. 2012. Two-step epigenetic Mendelian randomization: A strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol 41(1):161-176.
99. Ricobaraza A, Cuadrado-Tejedor M, Perez-Mediavilla A, Frechilla D, Del Rio J, Garcia-Osta A. 2009. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 34(7):1721-1732.
100. Rodriguez JJ, Witton J, Olabarria M, Noristani HN, Verkhratsky A. 2010. Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease. Cell Death Dis 1:e1.
101. Roth RB, Hevezi P, Lee J, Willhite D, Lechner SM, Foster AC, Zlotnik A. 2006. Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 7(2):67-80.
102. Rye PD, Booij BB, Grave G, Lindahl T, Kristiansen L, Andersen HM, Horndalsveen PO, Nygaard HA, Naik M, Hoprekstad D, Wetterberg P, Nilsson C, Aarsland D, Sharma P, Lonneborg A. 2011. A novel blood test for the early detection of Alzheimer's disease. J Alzheimers Dis 23(1):121-129.
103. Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ. 2006. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci USA 103(50):19176-19181.
104. Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, Glajch KE, Xia E, Qiu Z, Hersch SM, Clark TW, Yohrling GJ, Cha JH. 2007. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet 16(11):1293-1306.
105. Schalkwyk LC, Meaburn EL, Smith R, Dempster EL, Jeffries AR, Davies MN, Plomin R, Mill J. 2010. Allelic skewing of DNA methylation is widespread across the genome. Am J Hum Genet 86(2):196-212.
106. Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, Jaenisch R, Laird PW, Akbarian S. 2007. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2(9):e895.
107. Sleegers K, Lambert JC, Bertram L, Cruts M, Amouyel P, Van Broeckhoven C. 2010. The pursuit of susceptibility genes for Alzheimer's disease: Progress and prospects. Trends Genet 26(2):84-93.
108. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM. 1998. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam study. Arch Neurol 55(7):964-968.
109. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. 2011. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3):280-292.
110. Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA. 2006. Human postmortem tissue: What quality markers matter? Brain Res 1123(1):1-11.
111. Stein TD, Johnson JA. 2002. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 22(17):7380-7388.
112. Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403(6765):41-45.
113. Suarez-Quian CA, Goldstein SR, Pohida T, Smith PD, Peterson JI, Wellner E, Ghany M, Bonner RF. 1999. Laser capture microdissection of single cells from complex tissues. Biotechniques 26(2):328-335.
114. Szulwach KE, Li X, Li Y, Song CX, Wu H, Dai Q, Irier H, Upadhyay AK, Gearing M, Levey AI, Vasanthakumar A, Godley LA, Chang Q, Cheng X, He C, Jin P. 2011. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci 14(12):1607-1616.
115. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929):930-935.
116. Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Genda Y, Ukitsu M. 1999a. Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res Mol Brain Res 70(2):288-292.
117. Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Ukitsu M, Genda Y. 1999b. The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex. Neurosci Lett 275(2):89-92.
118. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL. 2000. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97(26):14720-14725.
119. Urdinguio RG, Sanchez-Mut JV, Esteller M. 2009. Epigenetic mechanisms in neurological diseases: Genes, syndromes, and therapies. Lancet Neurol 8(11):1056-1072.
120. van den Hove DL, Chouliaras L, Rutten BP. 2012. The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: Current status and prospects for future studies. Curr Alzheimer Res 9(5):545-549.
121. Wang SC, Oelze B, Schumacher A. 2008. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 3(7):e2698.
122. Wenk GL. 2003. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 64(Suppl. 9):7-10.
123. West MJ, Coleman PD, Flood DG, Troncoso JC. 1994. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344(8925):769-772.
124. West RL, Lee JM, Maroun LE. 1995. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J Mol Neurosci 6(2):141-146.
125. Whittemore SR, Sanon HR, Wood PM. 1993. Concurrent isolation and characterization of oligodendrocytes, microglia and astrocytes from adult human spinal cord. Int J Dev Neurosci 11(6):755-764.
126. Wong C, Meaburn E, Ronald A, Price J, Jeffries A, Schalkwy L, Plomin R, Mill J. 2013. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder (ASD) and related behavioural traits. Mol Psychiatry doi: 10.1038/mp.2013.41. [Epub ahead of print].
127. Wyatt GR, Cohen SS. 1953. The bases of the nucleic acids of some bacterial and animal viruses: The occurrence of 5-hydroxymethylcytosine. Biochem J 55(5):774-782.
128. Yu S, Zhang JZ, Zhao CL, Zhang HY, Xu Q. 2004. Isolation and characterization of the CD133+ precursors from the ventricular zone of human fetal brain by magnetic affinity cell sorting. Biotechnol Lett 26(14):1131-1136.
129. Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC. 2005. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol. 57(6):896-903.
130. Zhang K, Schrag M, Crofton A, Trivedi R, Vinters H, Kirsch W. 2012. Targeted proteomics for quantification of histone acetylation in Alzheimer's disease. Proteomics 12(8):1261-1268.